… cancer. In non–small cell lung cancer, bortezomib as a single agent has limited activity
but in combination with chemotherapy has shown encouraging activity without significantly …

… important when combining bortezomib with other … bortezomib was administered before the
G/C combination, there continued to be an increase in G 2 /M arrest as seen with bortezomib …

… of efficacy of bortezomib to gain a full understanding of its potential in lung cancer. Preclinical
… single-agent bortezomib and bortezomib in combination with conventional chemotherapy …

… Bortezomib has demonstrated in vitro chemotherapy- and RT–sensitizing properties as well
… activity in lung cancer. This article will review the rationale for the use of bortezomib as part …

… Albanell J, Baselga J, Guix M, et al: Phase I study of bortezomib in combination with
docetaxel in anthracycline-pretreated advanced breast cancer. Proc Am Soc Clin Oncol 22::16,2003, …

… This review focuses on the proteasome inhibitor bortezomib alone and in combination with
… Phase I study of bortezomib plus docetaxel in advanced non-small-cell lung cancer and …

… indicate that combination therapy of TRAIL and bortezomib may be an … combination treatment
of rhTRAIL and bortezomib, we made use of two previously established H460-derived cell …

… evaluate the efficacy and safety of bortezomib and pemetrexed alone or in combination, in
patients with previously treated advanced non-small-cell lung cancer (NSCLC). The primary …

… non-small cell lung cancer (NSCLC) A549 and H157 cells in vitro where it inhibited cell growth
and … In addition, we also demonstrated the combined usage of bortezomib and autophagy …

… , congestive cardiac failure in a lung cancer patient who had no prior cardiac history, after
receiving an experimental treatment of bortezomib combined with chemotherapy. Elevated …